Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)

NCT00228540 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.

NCT NCT00228540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00228540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)
Lead sponsor
Cephalon
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2006
Enrollment
Not reported
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

adhd